Tafasitamab is a type of medication that helps the immune system find and destroy cancer cells. It works by attaching to a specific protein found on the surface of certain cancer cells, making it easier for the body’s natural defenses to target and eliminate them. In this trial, tafasitamab is being tested to see if it can help treat certain types of lymphoma, which is a cancer of the lymphatic system.

Lenalidomide is a medication that helps the immune system fight cancer. It works by affecting the way the immune system functions, which can help slow down or stop the growth of cancer cells. Lenalidomide is used in this trial to see if it can improve the treatment of lymphoma when used with other medications.

Rituximab is a medication that targets specific cells in the immune system. It works by attaching to a protein on the surface of certain white blood cells, which can help destroy these cells when they are cancerous. Rituximab is commonly used to treat different types of lymphoma, and in this trial, it is being used to see if it can enhance the effectiveness of other treatments for lymphoma.

Follicular Lymphoma – Follicular lymphoma is a type of non-Hodgkin lymphoma that originates from B-lymphocytes, a kind of white blood cell. It typically progresses slowly and is characterized by the formation of tumors in the lymph nodes. Over time, it can spread to other parts of the body, including the bone marrow and spleen. The disease often presents with painless swelling of lymph nodes, fatigue, and sometimes fever or night sweats. As it advances, it may lead to more significant symptoms due to the involvement of multiple lymph nodes and organs. The progression can vary, with periods of stability followed by more active phases.

Marginal Zone Lymphoma – Marginal zone lymphoma is a type of non-Hodgkin lymphoma that arises from B-cells in the marginal zone of lymphoid tissue. It generally progresses slowly and can occur in various forms, including extranodal, nodal, and splenic types. The disease often presents with symptoms such as swollen lymph nodes, fatigue, and sometimes abdominal discomfort if the spleen is involved. It can spread to other lymphoid tissues and organs over time. The progression is typically indolent, with long periods of minimal symptoms. However, it can transform into a more aggressive form of lymphoma in some cases.